You can find the annual or quarterly income statement of Jin Medical International Ltd here for insights into the performance and operational efficiency of Jin Medical International Ltd.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
Total revenue
35.29%12.95M
2.96%10.56M
--9.57M
--10.25M
Revenue
35.29%12.95M
2.96%10.56M
--9.57M
--10.25M
Cost of revenue
13.69%7.18M
1.46%6.82M
--6.31M
--6.72M
Operating expenses
24.35%10.54M
9.97%9.33M
--8.47M
--8.48M
R&D expenses
-2.65%887.68K
-3.39%609.64K
--911.86K
--631.03K
Depreciation, depletion, and amortization
5.69%117.78K
46.90%168.15K
--111.44K
--114.47K
Operating profit
119.89%2.41M
-30.61%1.23M
--1.10M
--1.77M
Net non-operating interest income (expenses)
Gains from sale of securities
-311.63%-27.19K
100.65%414.00
--12.85K
---63.25K
Other non-operating income (expenses)
-94.43%3.05K
-39.05%102.16K
--54.77K
--167.63K
Income before tax
73.41%2.17M
2.18%2.01M
--1.25M
--1.97M
Income tax
225.71%454.87K
51.44%309.01K
--139.65K
--204.05K
Income after tax
54.28%1.72M
-3.51%1.70M
--1.11M
--1.77M
Net income from continuous operations
54.28%1.72M
-3.51%1.70M
--1.11M
--1.77M
Net Income attributable to non-controlling interests
---166.39K
---89.70K
----
----
Net income attributable to controlling interests
69.25%1.88M
1.57%1.79M
--1.11M
--1.77M
Net income attributable to common shareholders
69.25%1.88M
1.57%1.79M
--1.11M
--1.77M
Basic earnings per share
67.64%0.01
-12.17%0.01
--0.01
--0.01
Diluted earnings per share
67.64%0.01
-12.17%0.01
--0.01
--0.01
Dividend per share
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
FAQs
How do I read Jin Medical International Ltd's income statement on TradingKey?
Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.
What is the difference between quarterly and annual income statements?
A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.
What does YOY mean on the income statement page?
YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.
Which income statement metrics matter most when analyzing ZJYL stock?
Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.
What was Jin Medical International Ltd's revenue at year end?
Jin Medical International Ltd reported 20.69M in revenue for fiscal year 2025, up from 23.50M in the previous year.
How much revenue did Jin Medical International Ltd report in the most recent quarter?
Jin Medical International Ltd reported 12.95M in revenue for the most recent quarter, an increase of 35.29% year over year.
What was Jin Medical International Ltd's net income for the year?
Jin Medical International Ltd posted 1.19M in net income for fiscal year 2025.
How much net income did Jin Medical International Ltd post in the last quarter?
Jin Medical International Ltd reported 1.88M in net income for the latest quarter。
What was Jin Medical International Ltd's annual operating profit?
Jin Medical International Ltd's operating income was 608.18K for fiscal year 2025.
How is EPS related to the income statement?
EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.